198 related articles for article (PubMed ID: 9357388)
1. Isoniazid acetylation metabolic ratio during maturation in children.
Pariente-Khayat A; Rey E; Gendrel D; Vauzelle-Kervroëdan F; Crémier O; d'Athis P; Badoual J; Olive G; Pons G
Clin Pharmacol Ther; 1997 Oct; 62(4):377-83. PubMed ID: 9357388
[TBL] [Abstract][Full Text] [Related]
2. Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment.
Keller GA; Fabian L; Gomez M; Gonzalez CD; Diez RA; Di Girolamo G
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):292-302. PubMed ID: 24447650
[TBL] [Abstract][Full Text] [Related]
3. Isoniazid acetylation phenotyping in Saudi Arabs.
Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
[TBL] [Abstract][Full Text] [Related]
4. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
[TBL] [Abstract][Full Text] [Related]
5. Caffeine acetylator phenotyping during maturation in infants.
Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
[TBL] [Abstract][Full Text] [Related]
6. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
[TBL] [Abstract][Full Text] [Related]
8. Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazid.
Chien JY; Peter RM; Nolan CM; Wartell C; Slattery JT; Nelson SD; Carithers RL; Thummel KE
Clin Pharmacol Ther; 1997 Jan; 61(1):24-34. PubMed ID: 9024171
[TBL] [Abstract][Full Text] [Related]
9. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
Augustynowicz-Kopeć E; Zwolska Z
Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acetylation phenotype with genotype coding for N-acetyltransferase (NAT2) in children.
Zielińska E; Bodalski J; Niewiarowski W; Bolanowski W; Matusiak I
Pediatr Res; 1999 Mar; 45(3):403-8. PubMed ID: 10088662
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.
Schaaf HS; Parkin DP; Seifart HI; Werely CJ; Hesseling PB; van Helden PD; Maritz JS; Donald PR
Arch Dis Child; 2005 Jun; 90(6):614-8. PubMed ID: 15908628
[TBL] [Abstract][Full Text] [Related]
12. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
Miscoria G; Leneveu A; Walle C; Roux A
Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
[TBL] [Abstract][Full Text] [Related]
13. Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis.
Verhagen LM; Coenen MJ; López D; García JF; de Waard JH; Schijvenaars MM; Hermans PW; Aarnoutse RE
Pharmacogenomics; 2014 Feb; 15(3):285-96. PubMed ID: 24533708
[TBL] [Abstract][Full Text] [Related]
14. Population screening for isoniazid acetylator phenotype.
Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ
Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
[TBL] [Abstract][Full Text] [Related]
15. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
[TBL] [Abstract][Full Text] [Related]
16. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
[TBL] [Abstract][Full Text] [Related]
17. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
[TBL] [Abstract][Full Text] [Related]
18. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
[TBL] [Abstract][Full Text] [Related]
19. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
Singh SP; Pande JN; Khilnani GC; Kailash S
Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
[TBL] [Abstract][Full Text] [Related]
20. A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.
Cordes H; Thiel C; Aschmann HE; Baier V; Blank LM; Kuepfer L
Antimicrob Agents Chemother; 2016 Oct; 60(10):6134-45. PubMed ID: 27480867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
